Here’s the blurb..
|
The 9th Edition of the longest-standing annual report dedicated to Europe’s evolving and dynamic legal cannabis market is now available.
The European Cannabis Report: 9th Edition, endorsed by headline partner, Curaleaf Laboratories, offers the most up-to-date insights and analysis on the evolution of key cannabis markets across Europe, including: Germany, the UK, Switzerland, the Netherlands and the Czech Republic.
The report covers:
There is a free-to-download version of the report available (excludes market sizing analysis). For market sizing data and analysis, please see the paid-for packages available via the webpage. |
Medical: The current rate of progress in medical cannabis in Europe is significant, from both a regulatory and a market growth perspective.
Adult-Use: Adult-use cannabis in Europe has seen significant strides made over the past year, with the legal landscape incrementally shifting towards legalisation, most notably in Germany.
CBD: The European CBD industry has experienced a long period of regulatory stagnation, with Novel Food applications at the EU and UK level seemingly at a standstill.
Market Size: Forecasts for 30 European countries, broken down by year (2024-2028) and country. Patient population forecasts are also provided as part of the Medical Market Sizing Data & Analysis package.
